• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变自发缓解和低强度光动力疗法后 脉络膜厚度的变化。

Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.

机构信息

Department of Ophthalmology, Ewha Womans University, Seoul, Republic of Korea.

出版信息

Eye (Lond). 2013 Mar;27(3):387-91. doi: 10.1038/eye.2012.273. Epub 2013 Jan 4.

DOI:10.1038/eye.2012.273
PMID:23288136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3597877/
Abstract

PURPOSE

To assess the change in subfoveal choroidal thickness (SFCT) in central serous chorioretinopathy (CSC) following spontaneous resolution and low-fluence photodynamic therapy (PDT) using the enhanced depth imaging optical coherence tomography (EDI-OCT).

METHODS

A total of 36 consecutive eyes of 36 patients were included in this retrospective study: 16 eyes with spontaneously resolved CSC and 20 eyes with PDT-treated CSC. Best-corrected visual acuity and SFCT were evaluated at each visit until complete absorption of the subretinal fluid. SFCT of 32 normal subjects were also measured, as the control group. Wilcoxon's singed-rank test was used to evaluate the effects of spontaneous resolution and PDT. To compare the SFCT of the eyes with resolved CSC with that of the normal eyes, Mann-Whitney U-test with Bonferroni correction was also employed.

RESULTS

SFCT of patients was 459.16±77.50 μm at the baseline, and decreased to 419.31±54.49μm after a spontaneous resolution (P=0.015). However, SFCT was not normalized in comparison with that of the normal subjects (P<0.001). SFCT in PDT group was also reduced from 416.43±74.01 to 349.50±88.99 μm (P<0.001), with no significant difference with the normal value (P=0.087).

CONCLUSIONS

SFCT in patients with CSC decreased both after spontaneous resolution and low-fluence PDT. However, only in the PDT group, after disappearance of subretinal fluid, did it decrease to that of normal subjects.

摘要

目的

使用增强深度成像光学相干断层扫描(EDI-OCT)评估中心性浆液性脉络膜视网膜病变(CSC)自发消退和低强度光动力疗法(PDT)后中心凹下脉络膜厚度(SFCT)的变化。

方法

本回顾性研究共纳入 36 例 36 只眼:16 只眼为自发性 CSC 消退,20 只眼为 PDT 治疗的 CSC。每次就诊时均评估最佳矫正视力和 SFCT,直到视网膜下液完全吸收。还测量了 32 名正常受试者的 SFCT,作为对照组。Wilcoxon 符号秩检验用于评估自发消退和 PDT 的影响。为了比较消退的 CSC 眼与正常眼的 SFCT,还采用了校正后的 Mann-Whitney U 检验。

结果

患者基线时的 SFCT 为 459.16±77.50 μm,自发消退后降至 419.31±54.49 μm(P=0.015)。然而,与正常对照组相比,SFCT 并未恢复正常(P<0.001)。PDT 组的 SFCT 也从 416.43±74.01 降至 349.50±88.99 μm(P<0.001),与正常值无显著差异(P=0.087)。

结论

CSC 患者在自发消退和低强度 PDT 后 SFCT 均降低。然而,只有在 PDT 组,当视网膜下液消失后,SFCT 才降低至正常水平。

相似文献

1
Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.中心性浆液性脉络膜视网膜病变自发缓解和低强度光动力疗法后 脉络膜厚度的变化。
Eye (Lond). 2013 Mar;27(3):387-91. doi: 10.1038/eye.2012.273. Epub 2013 Jan 4.
2
Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.特发性中心性浆液性脉络膜视网膜病变患者接受黄斑外光动力疗法治疗后脉络膜厚度的变化。
Acta Ophthalmol. 2012 Dec;90(8):738-43. doi: 10.1111/j.1755-3768.2011.02157.x. Epub 2011 May 17.
3
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.治疗中心性浆液性脉络膜视网膜病变后脉络膜的中心凹下厚度。
Ophthalmology. 2010 Sep;117(9):1792-9. doi: 10.1016/j.ophtha.2010.01.023. Epub 2010 May 15.
4
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.三分之一剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的临床研究。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):278-284. doi: 10.26355/eurrev_201801_14169.
5
Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence.比较光动力疗法治疗中心性浆液性脉络膜视网膜病变的效果:全剂量与半剂量与半剂量-半光通量对比
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2155-2161. doi: 10.1007/s00417-019-04426-8. Epub 2019 Jul 31.
6
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变。
Retina. 2013 Feb;33(2):316-23. doi: 10.1097/IAE.0b013e318280769c.
7
Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.光学相干断层扫描血管造影评估半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后早期脉络膜毛细血管的变化:初步结果。
Photodiagnosis Photodyn Ther. 2018 Mar;21:375-378. doi: 10.1016/j.pdpdt.2018.01.015. Epub 2018 Feb 2.
8
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.聚焦式与传统维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Korean J Ophthalmol. 2019 Dec;33(6):506-513. doi: 10.3341/kjo.2019.0065.
9
CHOROIDAL THICKNESS AFTER FULL-FLUENCE AND HALF-FLUENCE PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.慢性中心性浆液性脉络膜视网膜病变患者接受全剂量和半剂量光动力治疗后的脉络膜厚度
Retina. 2015 Aug;35(8):1555-60. doi: 10.1097/IAE.0000000000000511.
10
Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.全剂量与半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的长期疗效
Ophthalmologica. 2019;241(2):105-115. doi: 10.1159/000490773. Epub 2018 Aug 15.

引用本文的文献

1
Volumetrically tracking retinal and choroidal structural changes in central serous chorioretinopathy.定量追踪中心性浆液性脉络膜视网膜病变中视网膜和脉络膜的结构变化。
Biomed Opt Express. 2023 Sep 29;14(10):5528-5538. doi: 10.1364/BOE.506422. eCollection 2023 Oct 1.
2
Short-Term Outcomes of Cataract Surgery in Patients with a History of Central Serous Chorioretinopathy.有中心性浆液性脉络膜视网膜病变病史患者白内障手术的短期预后
J Ophthalmol. 2021 Jun 24;2021:9952050. doi: 10.1155/2021/9952050. eCollection 2021.
3
Correlation between choroidal structure and smoking in eyes with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变眼脉络膜结构与吸烟的相关性。
PLoS One. 2021 Mar 23;16(3):e0249073. doi: 10.1371/journal.pone.0249073. eCollection 2021.
4
Assessment of choriocapillary blood flow changes in response to half-dose photodynamic therapy in chronic central serous chorioretinopathy using optical coherence tomography angiography.使用光学相干断层扫描血管造影术评估慢性中心性浆液性脉络膜视网膜病变中脉络膜毛细血管血流对半剂量光动力疗法的反应变化。
BMC Ophthalmol. 2020 Oct 7;20(1):402. doi: 10.1186/s12886-020-01674-9.
5
Biomarkers for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的生物标志物
Ther Adv Ophthalmol. 2020 Aug 24;12:2515841420950846. doi: 10.1177/2515841420950846. eCollection 2020 Jan-Dec.
6
Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.厚脉络膜疾病与年龄相关性黄斑变性的特征:多模态成像与遗传背景
J Clin Med. 2020 Jun 29;9(7):2034. doi: 10.3390/jcm9072034.
7
Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy.急性中心性浆液性脉络膜视网膜病变的复发风险及向慢性病的转变
Clin Ophthalmol. 2020 Apr 29;14:1165-1175. doi: 10.2147/OPTH.S242926. eCollection 2020.
8
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.聚焦式与传统维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Korean J Ophthalmol. 2019 Dec;33(6):506-513. doi: 10.3341/kjo.2019.0065.
9
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力治疗后视网膜外层微观结构的变化
Clin Ophthalmol. 2017 Aug 16;11:1505-1512. doi: 10.2147/OPTH.S139288. eCollection 2017.
10
Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.中心性浆液性脉络膜视网膜病变的黄斑下脉络膜厚度:一项荟萃分析。
PLoS One. 2017 Jan 11;12(1):e0169152. doi: 10.1371/journal.pone.0169152. eCollection 2017.

本文引用的文献

1
Half-fluence photodynamic therapy in acute central serous chorioretinopathy.急性中心性浆液性脉络膜视网膜病变的半剂量光动力疗法。
Retina. 2012 Nov-Dec;32(10):2014-9. doi: 10.1097/IAE.0b013e318242b9ab.
2
Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report.中心性浆液性脉络膜视网膜病变光动力疗法后脉络膜厚度的地形学变化:一例光学相干断层扫描病例报告
J Ophthalmol. 2012;2012:347206. doi: 10.1155/2012/347206. Epub 2012 Jan 12.
3
Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices.不同 SD-OCT 设备测量日本人正常眼黄斑中心凹下脉络膜厚度的重复性和可再现性。
Invest Ophthalmol Vis Sci. 2012 Mar 1;53(3):1102-7. doi: 10.1167/iovs.11-8836.
4
Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.单侧活跃性中心性浆液性脉络膜视网膜病变患者双眼脉络膜厚度。
Eye (Lond). 2011 Dec;25(12):1635-40. doi: 10.1038/eye.2011.258. Epub 2011 Oct 21.
5
Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.三种谱域光学相干断层扫描系统测量脉络膜厚度的可重复性。
Ophthalmology. 2012 Jan;119(1):119-23. doi: 10.1016/j.ophtha.2011.07.002. Epub 2011 Sep 23.
6
One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力治疗后 1 年的脉络膜厚度结果。
Retina. 2011 Oct;31(9):1921-7. doi: 10.1097/IAE.0b013e31822bf6b1.
7
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者对侧眼的中心凹下脉络膜厚度。
Retina. 2011 Sep;31(8):1603-8. doi: 10.1097/IAE.0b013e31820f4b39.
8
Review and update of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的复习与更新。
Curr Opin Ophthalmol. 2011 May;22(3):166-73. doi: 10.1097/ICU.0b013e3283459826.
9
The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography.增强深度成像光学相干断层扫描观察枸橼酸西地那非对脉络膜厚度的影响。
Retina. 2011 Feb;31(2):332-5. doi: 10.1097/IAE.0b013e3181eef0ae.
10
Central serous chorioretinopathy: an update on pathogenesis and treatment.中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/eye.2010.130. Epub 2010 Oct 8.